DLCO
Showing 1 - 25 of 786
Long COVID, Breathlessness, Exercise Intolerance Trial in Genoa (Lung volumes, spirometry and standard single-breath DLCO were
Completed
- Long COVID
- +4 more
- Lung volumes, spirometry and standard single-breath DLCO were measured at rest while combined DLNO and DLCO were measured at rest and post-exercise
-
Genoa, ItalyOspedale Policlinico San Martino IRCCS - S.S. Fisiopatologia Res
Jun 23, 2022
GOLD 0 - DLCO 1: A Look Beyond Obstruction. Is Spirometry Enough
Not yet recruiting
- COPD, Chronic Obstructive Pulmonary Disease
- Standard Care
- Standard Care plus oxidative stress study plus inflammation biomarkers study
-
Valencia, Valencian Community, SpainHospital Clínico Universitario de Valencia
Aug 16, 2021
Lung Diseases, Interstitial Trial (Spirometry, Diffusing Capacity of the Lung for Carbon Monoxide (DLCO), Magnetic Resonance
Not yet recruiting
- Lung Diseases, Interstitial
- Spirometry
- +4 more
- (no location specified)
Aug 8, 2022
Infants Born Premature
Recruiting
- Premature Lungs
- Diffusion Capacity of the Lung for Carbon Monoxide (DLCO)
-
Indianapolis, IndianaJeff Bjerregaard
Jan 20, 2022
Anti-Angiogenic Preeclampsia Milieu Impairs Infant Lung and
Completed
- Preeclampsia
- Diffusion Lung Capacity (DLCO), Vascular Challenge, Video Imaging, Specimen Collections
-
Indianapolis, IndianaRiley Hospital for Children
Feb 22, 2022
COPD-Related Physiology and the Brain
Recruiting
- Pulmonary Disease, Chronic Obstructive (COPD)
- Cognitive Impairment
- Neuropsychological Assessment
- +8 more
-
Iowa City, IowaCarinda Linkenmeyer
Apr 21, 2022
COVID-19, Fibrosis, Cohort Trial in Amiens
Recruiting
- COVID-19
- +5 more
-
Amiens, Picardie, FranceCHU Amiens Picardie
Oct 21, 2021
COVID-19 Related Lung Ventilation and Perfusion Injury
Recruiting
- Covid-19
- +2 more
- V/Q SPECT-CT
- +6 more
-
Hamilton, Ontario, CanadaSt. Joseph's Healthcare Hamilton
Sep 9, 2021
Ulcerative Colitis Trial in Japan (Etrasimod, Placebo)
Recruiting
- Ulcerative Colitis
- Etrasimod
- Placebo
-
Toyohashi-shi, Aichi- KEN, Japan
- +70 more
Jan 3, 2023
Biology of Diffusion Impairment in Human Immunodeficiency Virus
Active, not recruiting
- HIV Infections
- Pulmonary Disease
- PFT's (pulmonary function testing)
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh department of medicine division of Pulm
Oct 26, 2022
COPD Trial in Copenhagen (Acute exercise)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Acute exercise
-
Copenhagen, Denmark
- +1 more
Nov 17, 2022
Pulmonary Capillary Blood Volume in Pre- and Postcapillary
Completed
- Hypertension Pulmonary
- assessment of DLNO and DLCO
-
Graz, Steiermark, AustriaMedical University Graz, Division of Pulmonology
Mar 17, 2020
Interstitial Lung Disease Trial in Phoenix (Trans Sodium Crocetinate, Placebo)
Terminated
- Interstitial Lung Disease
- Trans Sodium Crocetinate
- Placebo
-
Phoenix, ArizonaPulmonary Associates, P.A.
Aug 8, 2022
Dapagliflozin on Cardiorespiratory Parameters in Heart Failure
Recruiting
- Heart Failure
- +4 more
-
Milan, ItalyCentro Cardiologico Monzino
Mar 3, 2023
Healthy Trial in Edmonton (Sildenafil 50 mg, Placebo)
Recruiting
- Healthy
- Sildenafil 50 mg
- Placebo
-
Edmonton, Alberta, CanadaClinical Physiology Laboratory
Apr 6, 2022
Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary
Active, not recruiting
- Non-Small Cell Lung Cancer
-
Aurora, Colorado
- +4 more
Jan 21, 2022
Clinical Assessments of Pulmonary Diffusing Capacity Trial in Copenhagen (Rest-to-exercise, Sitting-to-supine)
Completed
- Clinical Assessments of Pulmonary Diffusing Capacity
- Rest-to-exercise
- Sitting-to-supine
-
Copenhagen, DenmarkRigshospitalet
Nov 9, 2021
Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
Completed
- COVID
- +5 more
-
Monza, MB, ItalySan Gerardo Hospital
Apr 27, 2022
Covid19 Trial in La Jolla (Hyperbaric oxygen therapy)
Suspended
- Covid19
- Hyperbaric oxygen therapy
-
La Jolla, CaliforniaUniveristy of California San Diego
Jul 8, 2022
Eosinophilic Esophagitis Trial in Worldwide (Etrasimod, Placebo)
Active, not recruiting
- Eosinophilic Esophagitis
- Etrasimod
- Placebo
-
Birmingham, Alabama
- +222 more
Dec 8, 2022
Patients Receiving MMF for Diffuse Cutaneous or Pulmonary
Recruiting
- Systemic Sclerosis
- AUC of MPA measure
-
Paris, FranceCochin hospital, AP-HP
Nov 19, 2021
CPET to Predict Mortality and Complications of Lung Resection
Recruiting
- Exercise Test
- Thoracic Cancer
-
Brussels, BelgiumErasme Hospital
Aug 12, 2022
COVID-19 Trial in Rome (N-Acetylcysteine, Placebo)
Active, not recruiting
- COVID-19
- N-Acetylcysteine
- Placebo
-
Rome, Roma, ItalyFondazione Policlinico Agostino Gemelli IRCCS
Feb 20, 2023
Idiopathic Pulmonary Fibrosis Trial in Beijing, Shanghai (REGEND001, Placebo)
Recruiting
- Idiopathic Pulmonary Fibrosis
- REGEND001
- Placebo
-
Beijing, Beijing, China
- +2 more
Oct 7, 2023